Access

Insight

Nature 452, 580-589 (3 April 2008) | doi:10.1038/nature06917; Published online 2 April 2008

Open Innovation Challenges

naturejobs

Review Article Imaging in the era of molecular oncology

Ralph Weissleder1,2 & Mikael J. Pittet1

Top

New technologies for imaging molecules, particularly optical technologies, are increasingly being used to understand the complexity, diversity and in vivo behaviour of cancers. 'Omic' approaches are providing comprehensive 'snapshots' of biological indicators, or biomarkers, of cancer, but imaging can take this information a step further, showing the activity of these markers in vivo and how their location changes over time. Advances in experimental and clinical imaging are likely to improve how cancer is understood at a systems level and, ultimately, should enable doctors not only to locate tumours but also to assess the activity of the biological processes within these tumours and to provide 'on the spot' treatment.

MORE ARTICLES LIKE THIS

These links to content published by NPG are automatically generated.

NEWS AND VIEWS

A clearer vision for in vivo imaging

Nature Biotechnology Research News (01 Apr 2001)